Which vaccines does the ACIP recommend shared decision-making for?

The ACIP (Advisory Committee on Immunization Practices) emphasizes shared decision-making for specific vaccines that may have nuanced benefits based on individual patient circumstances. The recommendation for shared decision-making for the 9-valent HPV vaccine and Meningococcal ACWY vaccine acknowledges that the decision to vaccinate can depend on factors such as individual risk factors, age, and other personal health conditions.

For the 9-valent HPV vaccine, shared decision-making is important, particularly because the vaccine targets multiple strains of HPV that can lead to various cancers, and individuals may vary in their perception of risk and benefit based on their sexual practices, healthcare access, and education about HPV.

Similarly, for the Meningococcal ACWY vaccine, particularly in certain populations or settings, such as college students or travelers to endemic areas, the decision to vaccinate requires consideration of personal health history and potential exposure risks, thus making shared decision-making essential.

In contrast, other vaccines may have more standardized recommendations based on broader population benefits or less variability in individual risk assessment, which is why they do not require the same level of shared decision-making.